Latest Multiple Myeloma Research Consortium Stories

2011-09-20 22:26:59

Multicenter 1000-Patient Trial Initiated to Accelerate Development of Personalized Treatments for Multiple Myeloma The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma. The study is the centerpiece of the Multiple Myeloma Research Foundation´s (MMRF) Personalized...

2011-08-03 15:00:00

SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., Aug. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the Multiple Myeloma Research Foundation (MMRF) today announced the initiation of an expanded access program for carfilzomib, a selective, next-generation proteasome inhibitor. The Carfilzomib Myeloma Access Program (C-MAP) will include eligible patients in the United States (U.S.) with relapsed and refractory multiple myeloma. Expanded access programs make...

2011-06-25 00:00:30

S. 3988/A. 6233 will ensure that health plans already providing insurance coverage for chemotherapy will provide equal coverage for both IV/injected and oral therapies. The bill will be sent to the governor shortly. New York, NY (PRWEB) June 24, 2011 The New York Assembly voted unanimously 6/22/11 to pass S. 3988/A. 6233, a bill that will eliminate the disparity in insurance coverage between oral and intravenous chemotherapy therapies, ensuring that all cancer patients in the state have...

Word of the Day
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).